View PDF

Abstract:Amyotrophic lateral sclerosis (ALS) is a severe disease with a typical survival of 3-5 years after symptom onset. Current treatments offer only limited life extension, and the variability in patient responses highlights the need for personalized care. However, research is hindered by small, heterogeneous cohorts, sparse longitudinal data, and the lack of a clear definition for clinically meaningful patient clusters. Existing clustering methods remain limited in both scope and number. To address this, we propose a clustering approach that groups sequences using a disease progression declarative score. Our approach integrates medical expertise through multiple descriptive variables, investigating several distance measures combin…

Similar Posts

Loading similar posts...

Keyboard Shortcuts

Navigation
Next / previous item
j/k
Open post
oorEnter
Preview post
v
Post Actions
Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Recommendations
Add interest / feed
Enter
Not interested
x
Go to
Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Browse
gb
Search
/
General
Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help